Kidney failure. End stage renal disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 30-60 years BMI 18.5 - 30 At least 6 months of hemodialysis experience Ability and willingness to collaborate in the project
Exclusion criteria
Exclusion criteria: Underlying diseases including stage 3 and 4 heart failure, acute liver and thyroid disease, malignancy - Regular use of pomegranate supplements or juice in the past 3 months - Smoking, alcohol and hookah use - Use of steroidal and non-steroidal anti-inflammatory drugs - Severe reaction to syrups and placebo - Pregnancy during the study period - Hospitalization due to disease activation during the intervention - Patient withdrawal to cooperate in the study - Use of other anti-inflammatory and antioxidant supplements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FBS. Timepoint: Beginning and end of the study (tenth week). Method of measurement: Biochemical methods.;HbA1c. Timepoint: Beginning and end of study (tenth week). Method of measurement: ELISA kit.;Pentozidine. Timepoint: Beginning and end of study (tenth week). Method of measurement: ELISA kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| LDL. Timepoint: Beginning and end of study (tenth week). Method of measurement: Biochemical methods.;HDL. Timepoint: Beginning and end of study (tenth week). Method of measurement: Biochemical methods.;TC. Timepoint: Beginning and end of study (tenth week). Method of measurement: Biochemical methods.;TG. Timepoint: Beginning and end of study (tenth week). Method of measurement: Biochemical methods.;Urea. Timepoint: Beginning and end of study (tenth week). Method of measurement: Biochemical methods. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences